NQO1 and metabolic dysfunction-associated steatohepatitis: These results underscore the potential therapeutic significance of HucMSC-Exo exosomes, underscoring the Nrf2/NQO-1 pathway’s role in alleviating oxidative stress and inflammation in NASH (Kang et al., 2022).